Tolerance to SARS CoV-2 Vaccines Containing Polyethylene Glycol in Patients Allergic to Polysorbate 80.

Vidal Oribe, I; Venturini Díaz, M; Hernández Alfonso, P; Del Pozo Gil, M D; González Mahave, I; Lobera Labairu, T

Vidal Oribe, I; Venturini Díaz, M; Hernández Alfonso, P; Del Pozo Gil, M D; González Mahave, I; Lobera Labairu, T.

Affiliation

Vidal Oribe I; Allergy Department, Hospital San Pedro, Logroño, Spain.
Venturini Díaz M; Allergy Department, Hospital San Pedro, Logroño, Spain.
Hernández Alfonso P; Allergy Department, Hospital San Pedro, Logroño, Spain.
Del Pozo Gil MD; Allergy Department, Hospital San Pedro, Logroño, Spain.
González Mahave I; Allergy Department, Hospital San Pedro, Logroño, Spain.
Lobera Labairu T; Allergy Department, Hospital San Pedro, Logroño, Spain.

J Investig Allergol Clin Immunol ; 32(5): 403-405, 2022 10 11.

Article in En | MEDLINE | ID: mdl-34907899

Subject(s)

COVID-19; Severe Acute Respiratory Syndrome; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines; Humans; Polyethylene Glycols/adverse effects; Polysorbates/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Severe Acute Respiratory Syndrome / COVID-19 Limits: Humans Language: En Journal: J Investig Allergol Clin Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2022 Document type: Article Affiliation country: Spain Country of publication: Spain

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google